News

Dihexa for Long-Haul Cognitive Recovery in Shif...

Chronic sleep deprivation destroys synapses. Dihexa and Semax may rebuild them. But no human trial has tested these peptides in shift workers. The

Dihexa for Long-Haul Cognitive Recovery in Shif...

Chronic sleep deprivation destroys synapses. Dihexa and Semax may rebuild them. But no human trial has tested these peptides in shift workers. The

Semax for Post-GLP-1 Cognitive Recovery: Restor...

Semax may restore hippocampal BDNF after long-term oral semaglutide use. This article explains the science behind post-GLP-1 cognitive recovery and

Semax for Post-GLP-1 Cognitive Recovery: Restor...

Semax may restore hippocampal BDNF after long-term oral semaglutide use. This article explains the science behind post-GLP-1 cognitive recovery and

Semax as a Neuroprotective Adjunct to GLP-1 Ago...

Semax may protect the brain from cognitive side effects of GLP-1 agonists and reduce alcohol craving. This article explains the research without jargon.

Semax as a Neuroprotective Adjunct to GLP-1 Ago...

Semax may protect the brain from cognitive side effects of GLP-1 agonists and reduce alcohol craving. This article explains the research without jargon.

Semax and Selank Stack for Alcohol Cravings: A ...

Semax and Selank are nootropic peptides studied for cognition and anxiety. Could stacking them with GLP-1 therapy reduce alcohol cravings? This article

Semax and Selank Stack for Alcohol Cravings: A ...

Semax and Selank are nootropic peptides studied for cognition and anxiety. Could stacking them with GLP-1 therapy reduce alcohol cravings? This article

Dihexa and the VA’s GLP-1 Alcohol Trial: A Noot...

Dihexa is a synthetic peptide that may repair brain connections. The VA is testing GLP-1 drugs for alcohol use disorder in veterans. Could Dihexa serve as

Dihexa and the VA’s GLP-1 Alcohol Trial: A Noot...

Dihexa is a synthetic peptide that may repair brain connections. The VA is testing GLP-1 drugs for alcohol use disorder in veterans. Could Dihexa serve as

Dihexa and the FDA Panel’s Peptide Endorsement:...

A 2024 FDA panel endorsement of a peptide drug raises questions about the future of nootropic peptides like Dihexa. This article explains Dihexa’s

Dihexa and the FDA Panel’s Peptide Endorsement:...

A 2024 FDA panel endorsement of a peptide drug raises questions about the future of nootropic peptides like Dihexa. This article explains Dihexa’s